The best companies that have developed stronger during the pandemic.
There is a saying that in every dark cloud there is a silver lining. Amidst the catastrophe, the COVID-19 pandemic has brought some notable opportunities for investors and companies, as well. Some of the industries have highly benefited such as the medicine and pharmaceutical companies have gone bullish following the vaccine development.
For investors, if you’re looking for a secure investment and maximization of your wealth the best option is to go with well-positioned market leaders and hold them for a long period. So, we will be looking at the three top coronavirus stocks that could be a buy anytime soon.
The emerging financial services, merchant services aggregator, and mobile payment company, Square (SQ) is shaping up the future fintech world. As retail sales shifting online and during the pandemic, it has accelerated the pace of digital glory.
Customer sales are continuing to rise and many companies have heavily relied on their online sales during all the four quarters of 2020. In that premise, the businesses are planning to go online and make it their primary source of sale.
Square is slightly on the downward move since pumping early in this month. Investors need to follow square as the stock could be at a perfect buy position in the next week or so.
CVS Health (CVS)
CVS Health (CVS) is a healthcare firm that owns CVS Pharmacy, runs a retail chain; CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance provider, among many other brands.
The company’s acquisition strategy has made it a powerful force in the healthcare industry. For instance, by transforming its network from drug stores to clinics, CVS has earned ways to make profits. The company leads the drug store market with over 10,000 retail locations, 1,100 MinuteClinics, and 450 HealthHub locations across the country.
Moreover, the company is taking a full part in the COVID-19 cycle. CVS is conducting almost 70% of the coronavirus tests and has a major stake in the US’s coronavirus vaccination effort. Analysts believe that the company can generate an additional $1 billion in gross profit from the COVID-19 immunizations. So, CVS Health (CVS) shares could shoot higher by the end of 2021.
With a massive boom in pet ownership during the epidemic, Freshpet (FRPT) has much in the tank to make its investors rich. The company specializes in pet food products, especially its dog and cat food products have been in huge demand lately.
The company has a stronghold at the retail level, with its branded refrigerators installed in over 22,000 supermarkets and other retailers. So, the company is well-positioned to maintain profits from the rising pet market. In the last year, Americans have spent over $99 billion on pet products including food.
Freshpet (FRPT) ended the full-year with a total sale of $318.8 million, up by 30% year-over-year. The has forecasted its sales to approximately triple to $1 billion by 2025. So, FRPT could be a handsomely attractive stock with potential gains for the investors.